Current status on aortic endografts

J Cardiovasc Surg (Torino). 2020 Oct;61(5):544-554. doi: 10.23736/S0021-9509.20.11614-8. Epub 2020 Sep 23.

Abstract

Endovascular treatment has become widespread to treat aneurysmal disease, especially located in the aorta. The modern era of abdominal aortic aneurysm repair started between 1986 and 1991, and in the last 30 years, Endovascular Treatment for abdominal aortic aneurysms evolved both due to the development of new materials and devices and the increasing appeal and effectiveness of the endovascular therapy itself. Vascular surgeons are using nowadays different solutions of Endovascular Treatment to treat all the expressions of aortic pathology (aneurysms, dissections and trauma) both in the acute and elective setting. Despite its use in every location of the aorta (the ascending aorta, the aortic arch, the thoracic aorta, thoraco-abdominal aorta, pararenal, iuxtarenal and infrarenal aortic aneurysms and iliac aneurysms), its safety and efficiency, endovascular treatment for aortic aneurysms presents some drawbacks: despite a lower short-term morbi-mortality, reinterventions and long-term patency are higher compared to open repair. In this review, we detail the most used types of endografts according to location, their performances and durability for each device. We conclude by discussing options to overcome ET limitations. Therefore, an obvious question arises: what we need in the future? What can the technological progress gives to physicians to further improve this new way of treating aorta?

Publication types

  • Review

MeSH terms

  • Animals
  • Aorta / physiopathology
  • Aorta / surgery*
  • Aortic Diseases / physiopathology
  • Aortic Diseases / surgery*
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis* / adverse effects
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / instrumentation*
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / physiopathology
  • Humans
  • Prosthesis Design*
  • Prosthesis-Related Infections / etiology
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome
  • Vascular Patency